![]()
|
|
||||||||
J. Biol. Chem., Vol. 262, Issue 20, 9859-9864, 07, 1987
JE Casnellie
The LSTRA cell line contains an elevated level of a tyrosine protein kinase
of apparent molecular weight of 56,000 (pp56Tcell). Analysis of the tryptic
fragments of this protein labeled in vivo with 32P shows that it contains
four sites of tyrosine phosphorylation and one site of serine
phosphorylation. Two of the sites of in vivo tyrosine phosphorylation are
also labeled in vitro when membranes are incubated with [gamma-32P]ATP. One
of the sites that is labeled in vivo and in vitro (site 1) is identical in
sequence with the major site of tyrosine phosphorylation in the
transforming protein of the Rous sarcoma virus. Analysis of the sites of in
vivo phosphorylation in pp56Tcell from LSTRA cells treated with 4
beta-phorbol 12 beta-myristate 13 alpha- acetate (PMA) reveals that this
agent induces at least four new sites of serine phosphorylation. Treatment
with PMA also causes a selective reduction in the level of tyrosine
phosphorylation in site 1. Thus PMA causes new sites of serine
phosphorylation in pp56Tcell and reduces the amount of phosphate in one of
the sites of tyrosine phosphorylation.
Sites of in vivo phosphorylation of the T cell tyrosine protein kinase in LSTRA cells and their alteration by tumor-promoting phorbol esters
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Y. Lu and A. I. Cederbaum Cisplatin-Induced Hepatotoxicity Is Enhanced by Elevated Expression of Cytochrome P450 2E1 Toxicol. Sci., February 1, 2006; 89(2): 515 - 523. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |